Evosep
AcquiredOdense, Denmark · $40.0M raised
- Headquarters
- Odense
- Website
- evosep.com
- Total Funding
- $40.0M
- Last Round
- $40.0M Venture RoundJan 2023
- Rounds
- 1
- Acquisition Date
- Nov 2025
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Evosep is a leading Danish innovator of sample preparation and separation solutions for LC-MS-based proteomics. By simplifying complex proteomics processes, Evosep empowers laboratories to deliver deeper biological insights and accelerate discoveries that benefit modern healthcare and life sciences.
Summary
Evosep is a Biotech company based in Odense, Denmark. It has raised $40.0M in total across 1 round, most recently a $40.0M Venture Round in Jan 2023. Investors include Nordic Capital and Novo Holdings A/S.
Funding History
Nov 2025
Sign up to see all 2 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/evosep"><img src="https://indexed.vc/api/badge/company/evosep" alt="Evosep on Indexed.vc" width="260" height="76" /></a>